Related Experiment Video
Updated: Dec 25, 2025
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family
Yuxiang Lin1, Jianxing Zhang2, Xiaoli Li1
1Research Center for Molecular Diagnosis of Genetic Diseases, Dongfang Hospital, Xiamen University Medical College, Fuzong Clinical College of Fujian Medical University, 156, Xi'erhuanbei Road, 350025 Fuzhou, Fujian, China.
Background:
Neonatal sclerosing cholangitis (NSC) is a severe cholestatic liver disease, which often develops into end-stage liver disease in childhood and requires liver transplantation. Mutations in CLDN1 and DCDC2 are confirmed to be the main pathogenic mechanism of NSC.
Methods:
Whole exon sequencing (WES) was performed to find the possible disease-causing mutations of this family. The mutation was confirmed by Sanger sequencing, and large fragment copy number variation was confirmed by qPCR.
Results:
We found novel biallelic mutations c.[705-2A>G];[923_1023del] in the DCDC2 gene of the proband. The proband's father had the heterozygous mutation c.705-2A>G, and his mother had a heterozygous c.923_1023del. The proband's younger brother, who had similar clinical manifestations, was found the same biallelic mutations with the proband.
Conclusion:
Novel biallelic mutations were identified in DCDC2 of this Chinese family, according to the American College of Medical Genetics and Genomics (ACMG) guidelines for interpretation of sequence variants, both mutations were classified as pathogenic, which might be the cause of NSC in this family.
